Ten weeks of daily oral CBD oil (10 mg/kg) in rats caused no structural liver damage, though the number of Kupffer cells (immune cells in the liver) increased significantly, especially near portal zones.
Toxicologists, hepatologists, and CBD product safety researchers.
What the researchers found
No pathohistological changes were observed in rat liver sinusoids after 10 weeks of daily CBD oil. However, Kupffer cell numbers increased significantly in all zones of the liver lobule (p<0.001), with a 1.58-fold increase near the portal zone. Perisinusoidal (stellate) cells remained the least abundant cell type. The study concluded CBD oil was safe for long-term liver exposure.
Why it matters
Liver safety is a key concern for CBD, given Epidiolex's liver enzyme warning. This study provides histological evidence that long-term oral CBD at a moderate dose does not cause structural liver damage, though the Kupffer cell increase suggests the liver's immune cells are responding to chronic CBD exposure.
The numbers in context
14 treated rats, 6 controls. 10 mg/kg/day for 10 weeks. No pathological liver changes. Kupffer cells increased 1.58-fold in portal zone (p<0.001). Significant increase in all lobule zones. Perisinusoidal cells remained lowest count.
How the study worked
20 male rats: 14 received daily oral CBD oil (10 mg/kg) for 10 weeks, 6 controls received hemp seed oil. Histological, immunohistochemical, and morphometric analyses of liver sinusoidal cell composition with statistical analysis (p<0.05 threshold).
What this study cannot tell us
Small sample (14 treated, 6 controls). Single dose tested (10 mg/kg). Male rats only. 10-week duration may not capture very long-term effects. CBD oil composition not fully characterized. Histological assessment may miss functional changes detectable only by blood tests or metabolomics.
How to read the evidence
Appropriate histological and immunohistochemical methods with statistical analysis, but small sample, single dose, and single species limit the conclusions.
When this study was published
Published 2025.
The bigger picture
The Kupffer cell increase without structural damage suggests CBD activates hepatic immune surveillance without causing harm. This could be either a benign adaptive response or an early signal of immune-mediated liver changes that might manifest with longer exposure or higher doses.
Questions still open
- Whether the Kupffer cell increase has functional consequences at longer time points or higher doses
- Whether this Kupffer cell activation relates to the liver enzyme elevations seen with high-dose CBD in clinical settings
Common questions
Is long-term CBD safe for the liver?
What are Kupffer cells?
Read the original research
Qualitative and quantitative analysis of rat liver sinusoids under condition of a long-term experimental exposure to cannabidiol oil.
Wiadomosci lekarskie (Warsaw, Poland : 1960), 78(12), 2611-2619
Citation
Shevchuk, Mykola M; Volos, Liliya I; Kovalska, Oksana R. (2025). Qualitative and quantitative analysis of rat liver sinusoids under condition of a long-term experimental exposure to cannabidiol oil.. Wiadomosci lekarskie (Warsaw, Poland : 1960), 78(12), 2611-2619. https://doi.org/10.36740/WLek/215799
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk